ABVIE INC. Stock Hits Price Target Forecast with 30.88% Profit - QuantWave Analysis
October 1, 2025
ABBVIE INC. Hits Forecasted Price Target for 25.87% Profit: A Comprehensive Analysis
October 1, 2025
ABBVIE INC. Hits Price Target Forecast with 33.03% Profit, Validates QuantWave's Analytics
October 1, 2025
ABBBVIE INC. Stock Hits Price Target Forecast with 18.46% Profit, Validating QuantWave's Analytics
October 1, 2025
ABBEVIE INC. Hits QuantWave Forecast Price Target with 18.24% Profit
October 1, 2025
ABBBVIE INC. Hits Price Target Forecast with 14.97% Profit
October 1, 2025
AbbVie ABBV Stock Shows Resilience Amid Market Turmoil
December 21, 2024
AbbVie Executives to Present at Citi's 2024 Global Healthcare Conference
November 27, 2024
AbbVie Inc. ABBV: A Higher-Yielding Healthcare Play That Continues to Shine
March 19, 2025
AbbVie Inc ABBV Q3 2024 Earnings: Revenue Beats at 14.46B GAAP EPS Misses at 0.88
October 30, 2024
AbbVie Inc. ABBV: A Promising Investment in the Pharmaceutical Industry
January 4, 2025
Investor opinions & comments
To leave a comment, you need to Login or Register.
LoganWard
December 2, 2024 at 06:31
AbbVie's strong position in the industry and promising projects make it an attractive investment option
ProfitPat
December 1, 2024 at 21:27
AbbVie's performance and growth potential are highly regarded by professionals in the healthcare sector
BudgetBobby
December 1, 2024 at 12:47
I'm not convinced that AbbVie's recent achievements will translate into long-term success in the healthcare sector
InvestorIsabella
November 30, 2024 at 09:23
I'm skeptical about hedge funds' interest in AbbVie. It could be a short-term trend rather than a reflection of the company's actual prospects
InvestorIvory
November 29, 2024 at 14:02
AbbVie's recent developments and acquisitions show that they are proactive in expanding their presence in the healthcare industry
SavingsSam
November 29, 2024 at 13:58
I trust Stocks Prognosis for accurate stock forecasts. I'll definitely check their analysis on AbbVie
TraderTobias
November 29, 2024 at 08:01
I'm interested to see how AbbVie's stock performs after their presentation at the Citis conference
MeganMason
November 29, 2024 at 07:00
This is great news! I'm excited to hear about AbbVie's innovative projects and future plans